Skip to the page

Data / Form D filings / Aerami Therapeutics Holdings, Inc.

Aerami Therapeutics Holdings, Inc.: Form D filings

Aerami Therapeutics Holdings, Inc., a health care company in Durham, NC, filed 13 Form D notices with the SEC between 2015 and 2023. The latest, on November 22, 2023, reports $1 million sold of a $20 million offering to 30 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
600 Park Offices Dr., Ste. 300, Durham, NC, 27709
Phone
(919) 797-9792
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1650840

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 22, 2023New notice$20,000,000$1,016,000$18,984,00030Nov 9, 2023sec.gov
Dec 16, 2022New notice$20,000,000$5,380,000$14,620,00039Oct 31, 2022sec.gov
Nov 4, 2021Amendment$22,250,560$22,250,560238Sep 17, 2021sec.gov
Sep 23, 2021New notice$20,000,000$2,200,000$17,800,00028Sep 17, 2021sec.gov
Jun 17, 2020New notice$15,000,000$4,608,000$10,392,00061Jun 5, 2020sec.gov
Jun 11, 2019Amendment$59,200,000$21,046,000$38,154,000283Jan 7, 2019sec.gov
Jun 10, 2019New notice$59,200,000$21,046,000$38,154,000283Jan 7, 2019sec.gov
Jan 11, 2018Amendment$36,699,455$19,033,459$17,665,996135Nov 30, 2017sec.gov
Dec 18, 2017New notice$40,000,000$14,696,404$25,303,596100Nov 30, 2017sec.gov
Jun 26, 2017Amendment$5,000,000$3,424,404$1,575,59649Apr 7, 2017sec.gov
Apr 26, 2017New notice$5,000,000$837,604$4,162,3965Apr 7, 2017sec.gov
Aug 4, 2016New notice$23,000,000$625,000$22,375,0002Jun 20, 2016sec.gov
Oct 2, 2015New notice$40,000,000$10,134,033$29,865,967135Sep 30, 2015sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Gary C. BurgessExecutive Officer
Anne C. WhitakerExecutive Officer, Director
Adam K. SternDirector
John S. PattonDirector
Steven C. ThorntonDirector
William Patrick WelchDirector
Joshua S. ZielExecutive Officer
Darlene C. Deptula-HicksExecutive Officer, Director

Other health care companies in North Carolina that filed recently

Every Form D from the week of Nov 20, 2023 · All recent filings in North Carolina · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Aerami Therapeutics Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.